Subscribe Now
Forgot Password?

Weekly News, Analysis, and Commentary

Legal & Regulatory Feature

Centric Medical Foot and Ankle Plating System / Courtesy of Centric Medical

FDA Quickly Clears Foot and Ankle Plating System

Walter Eisner • Fri, February 16th, 2018

Print this article

Distal extremity device maker Centric Medical has a new FDA 510(k) clearance for its foot and ankle plating system.

The company, a division of Life Spine, Inc., announced on January 23, 2018, that the FDA clearance offers "multiple surgical solutions" by the company to be used in foot and ankle reconstruction procedures.

"The Centric Medical Foot and Ankle Plating System," states a company press release, "is comprised of a variety of plates and screws intended to stabilize and fixate bone for a myriad of procedures. The low-profile plates and self-drilling and self-tapping screws were designed to minimize soft tissue disruption and irritation.

"They are offered in non-sterile, single use implantable components and are provided in a multitude of sizes and shapes which include plates specifically designed for metatarsal phalangeal fusions, lapidus fusions, midfoot fusions and calcaneal slide osteotomies."

"When paired with our recently FDA cleared Cannulated Screw Internal Fixation System, and our existing OSTEO-LINK DBM biologics product, we have the potential for excellent clinical outcomes,” said Life Spine Vice President of Marketing Mariusz Knap. “As one of the fastest-growing, most innovative companies in our space it is crucial to our surgeons and patients that we continue to advance our offerings.”

Indications for Use

According to the FDA clearance notification, the system is indicated for use in "stabilization and fixation of fractures or osteotomies; intra and extra articular fractures, joint depression, and multifragmentary fractures; revision procedures, joint fusions, and reconstruction of the bones of small bones of the toes, feet and ankles including the distal tibia, talus, and calcaneus. The system can be used in both adult and pediatric patients."

The clearance request was received by the agency on November 8, 2017 and cleared by December 21, 2017.

The company is privately held and based in Huntley, Illinois.

Send to a Friend

The article link will be sent to the email address you provide

Your Name (required)

Your Email (required)

Friend's Email (required)


Leave a Reply


Email Address (will not be published)